Creation of a Clinical Database on Primary Nervous System Tumors
Recruiting now
Conditions studied: Nervous System Tumor
In brief
the creation of a clinical database including data for all PCNST patients is of high interest. This database will allow us to develop clinical studies on: * The clinical, radiological and biological presentation of tumors, the impact of oncological treatments and the evaluation of survival for the different subtypes of Primary central nervous system tumors (PCNST). This is particularly important for rare histological subtypes of PCNST for which the current knowledge is scarce; * Clinical, radiological and biological factors predictive of tumor response to treatments; * Prognostic factors.
Key facts
- Study ID
- NCT04516720
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
- People needed
- 1700
- Starts
- 2018-01-01
- Expected to finish
- 2039-01-01
- Last updated by the study team
- 2025-02-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patient aged ≥ 18, no age limit;
- Diagnosis of Primary central nervous system tumors ;
- Patient treated at the Montpellier Cancer Institute, whatever the treatment received (systemic treatment, radiotherapy or exclusive supportive care);
- For the retrospective part of the study, patient first treated at the Montpellier Cancer Institute between January 1rst, 2004 and the beginning of the prospective part;
- Patient information for the retrospective (patient still alive at the beginning of the study) and prospective study.
You may not qualify if…
- Secondary lesions of the central nervous system;
- Patient not affiliated to a social protection scheme;
- Subject under tutelage, curatorship or safeguard of justice.
Where it is running
- Icm Val D'Aurelle — Montpellier, Herault, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.